W. Lin

Prevalence of chronic kidney disease in patients with chronic hepatitis B: A cross‐sectional survey

Jian Sun, Xieer Liang, J. Hou, 2017, Journal of viral hepatitis.

Studies on the interference of ganciclovir to HCV liver fibrosis.

Chenwei Pan, Peipei Fang, L. Zhuge, 2016, European review for medical and pharmacological sciences.

[Prevalence and risk factors of nonalcoholic fatty liver disease in patients with chronic hepatitis B receiving antiviral therapy].

H. Gao, R. Fan, Z. Kuang, 2019, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon‐α in interferon nonresponders with chronic hepatitis C

C. Datz, R. Stauber, P. Ferenci, 1999, Journal of viral hepatitis.

Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study Group.

C. Datz, R. Stauber, P. Ferenci, 2001, European journal of gastroenterology & hepatology.

463 PHARMACOKINETIC INTERACTIONS BETWEEN THE HCV PROTEASE INHIBITOR BOCEPREVIR AND SIROLIMUS IN HEALTHY SUBJECTS

J. Butterton, Hwa-ping Feng, F. Xuan, 2013 .